EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma

Cameron S Lewis iD, Allison Barraclough iD, Eliza A Hawkes iD

Blood · 2025

DOI: 10.1182/blood.2024025772 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood, 2025. Verfasst von Cameron S Lewis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Austin Health, Melbourne, Australia. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Biomarkers, Tumor, CD3 Complex, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel CD3×CD20 bispecific antibody (BsAb) immunotherapies have entered the armamentarium for follicular lymphoma and diffuse large B-cell lymphoma based on accelerated approvals. The primary challenge in utilizing BsAbs lies in patient selection due to variable responses, unique toxicity, and health economics. To date, no validated biomarkers of therapy response exist, however data demonstrating potential clinical, imaging, and biological markers relating to BsAbs are growing. This review examines current prognostic and potentially predictive biomarkers and explores future directions for nuanced patient selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificBiomarkers, TumorCD3 ComplexLymphoma, Large B-Cell, DiffuseLymphoma, FollicularReceptors, IgGHumansAntigens, CD20Prognosis

Substanzen

Antibodies, BispecificBiomarkers, TumorCD3 ComplexAntigens, CD20Receptors, IgG

Autor:innen und Institutionen

  • Department of Hematology, Austin Health, Melbourne, Australia.
  • Department of Hematology, Fiona Stanley Hospital, Perth, Australia.
  • Olivia Newton-John Cancer Research Institute, La Trobe University, Melbourne, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

ORCID-Profile: Cameron S Lewis, Allison Barraclough, Eliza A Hawkes

Zitieren

APA

Lewis, C. S., Barraclough, A., & Hawkes, E. A. (2025). Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma. Blood. https://doi.org/10.1182/blood.2024025772

Vancouver

Lewis CS, Barraclough A, Hawkes EA. Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma. Blood. 2025. doi:10.1182/blood.2024025772

BibTeX
@article{Lewis2025,
  author = {Lewis, Cameron S and Barraclough, Allison and Hawkes, Eliza A},
  title = {Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma},
  journal = {Blood},
  year = {2025},
  doi = {10.1182/blood.2024025772}
}
Kostenlos starten →